Wikidata

(Q64655553)

English

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

clinical trial

In more languages

Statements

short name
QUALITY (English)
0 references
title
A Post-marketing Observational Study of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic DMARDs Over a Period of 1 Year (QUALITY) (English)
0 references
country
Austria
0 references
start time
November 2008
0 references
end time
April 2011
0 references
number of participants
46
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64655553&oldid=1857883983"